Zdrowie i gospodarka · 30/04/2026
FDA Clears OZEMPIC (Semaglutide) Solution for Continued Sale
The FDA has determined that OZEMPIC solution, 2mg/1.5mL, was not withdrawn from sale due to safety or effectiveness concerns, allowing it to continue being approved for use in ANDAs.